Multiple sclerosis trials in Ireland
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Dublin
- Age
- 18 years to 65 years
- People
- 1,275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - No phaseTaking peoplePregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- Where
- Dublin
- People
- 908 worldwide
- Run by
- Biogen
See details and how to joinNCT05658497 - Phase 3Taking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Dublin 24, Dublin 8, Dublin 9
- Age
- 18 years and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00 - Phase 2Not yet taking people in IrelandImplementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
- Where
- Dublin
- Age
- 18 years and over
- People
- 94 worldwide
- Run by
- Danish Multiple Sclerosis Hospitals
See details and how to joinNCT07310914